Skip to content
HowShorted

IGM Biosciences, Inc. short interest in 2023

In 2023, IGM Biosciences, Inc.'s disclosed short interest ran from 8.45% of shares outstanding on 13 Jan 2023 to 7.99% on 29 Dec 2023, a change of -0.46 percentage points. The year's high was 11.49% on 14 Jul 2023 and its low 7.04% on 30 Nov 2023, averaging 8.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 33.28 days on 31 Aug 2023. Full history: IGM Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for IGM Biosciences, Inc. in 2023

2023 in figures

Start of year
8.45% (13 Jan 2023)
End of year
7.99% (29 Dec 2023)
Change
-0.46 pp
High
11.49% (14 Jul 2023)
Low
7.04% (30 Nov 2023)
Average
8.99%
Highest days to cover
33.28 (31 Aug 2023)
SEC filings marked
9

Every report in 2023

IGM Biosciences, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20238.45%13.84results (8-K)
31 Jan 20238.88%24.43
15 Feb 20238.48%18.80
28 Feb 20238.28%25.91
15 Mar 20238.60%29.55
31 Mar 20238.48%12.4510-K filed, results (8-K)
14 Apr 20239.10%9.46
28 Apr 20239.41%20.68
15 May 20239.63%18.7710-Q filed, results (8-K)
31 May 202310.11%22.34
15 Jun 202310.37%13.31
30 Jun 202311.22%6.54
14 Jul 202311.49%20.08
31 Jul 20238.36%30.21
15 Aug 20239.39%21.8510-Q filed, results (8-K)
31 Aug 20239.67%33.28
15 Sep 20239.62%20.16
29 Sep 20238.99%21.80
13 Oct 20239.13%13.54
31 Oct 20238.56%16.16
15 Nov 20237.10%10.7910-Q filed, results (8-K)
30 Nov 20237.04%13.78
15 Dec 20237.42%11.71
29 Dec 20237.99%14.84

See also: IGM Biosciences, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.